RIAN ROWLES: Open Payments
NPI 1447398870 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,553 in 128 payments from 17 companies in 2025. Trend: 2023 $3,372 · 2024 $2,696 · 2025 $3,553
Food & beverage: $3,553
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 19 | $568 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $528 |
| ABBVIE INC. | 12 | $452 |
| JAZZ PHARMACEUTICALS INC. | 11 | $388 |
| Vanda Pharmaceuticals Inc. | 12 | $308 |
| Neurocrine BioSciences, Inc. | 9 | $216 |
| Otsuka America Pharmaceutical, Inc. | 9 | $193 |
| E.R. Squibb & Sons, L.L.C. | 8 | $181 |
| Axsome Therapeutics, Inc. | 6 | $131 |
| Alkermes, Inc. | 6 | $109 |
Products named: CAPLYTA, SPRAVATO, VRAYLAR, XYWAV, FANAPT, REXULTI, INGREZZA, COBENFY.
Industry payments across IL — which companies pay providers there.
